Recommended monitoring protocol: Baseline: Full thyroid panel (TSH, free T4, free T3, TPO antibodies, thyroglobulin antibodies) plus thyroid ultrasound before starting GLP-1 therapy 6-8 weeks after starting GLP-1: Recheck TSH and free T4
The abdomen is still considered the most consistent option during early titration phases, but the thigh performs very well across the full dose range
The FDAs current 503A list places GHK-Cu, except for injectable routes of administration, in Category 1
showed less pain, lower inflammation (CRP), and better cholesterol and blood pressure
All different parts of the body use and contain reduced glutathione but most of the bodys supply is located in the lungs and liver
If your new vial looks noticeably different from your previous one but still falls within the pink-to-light-red range and remains clear without particles, it is likely fine